Journals & Publications
Bladder Cancer Journal
Bladder Cancer is an international multidisciplinary journal published by IOS Press. It facilitates progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the bladder and upper urinary tract. The journal’s Editors-in-Chief are Seth P. Lerner, MD (Baylor College of Medicine, Houston, TX, USA) and Dan Theodorescu, MD, PhD (University of Colorado Cancer Center, Aurora, CO, USA). Included in the quarterly publication are research reports, reviews, short communications, and letters-to-the-editor. In addition, the journal will also have a “News and Views” section for timely commentary. Launched in 2015, the journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of tumors of the bladder and upper urinary tract. Users of the Grand Rounds in Urology website can access research published in the journal via the ‘Topics’ link above, and at: http://
Kidney Cancer Journal
Kidney Cancer is an international multidisciplinary journal published by IOS Press. It facilitates progress in understanding the epidemiology/etiology, genetics, molecular correlates, pathogenesis, pharmacology, ethics, patient advocacy and survivorship, diagnosis and treatment of tumors of the kidney. The journal’s Editors-in-Chief are Primo N. Lara Jr, MD (University of California Davis Comprehensive Cancer Center Sacramento, CA, USA) and Peter Mulders, MD, PhD (Radboud UMC, Nijmegen, The Netherlands). Included in the biannual publication are research reports, reviews, short communications, and letters-to-the-editor. Launched in 2017, the journal is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of tumors of the kidney. Users of the Grand Rounds in Urology website can access research published in the journal via the ‘Topics’ link above, and at http://journalkidneycancer.
PCa Commentary
The PCa Commentary was commenced in October 2002 as a project to bring to clinicians working the prostate cancer field new information about clinically relevant developments in diagnosis, staging, imaging, and treatment — and place this information into the context of a basic science background. The articles are based on literature research of a variety of sources which the busy clinician may not have the time to peruse. In most instances the text has been reviewed by an expert in the subject under discussion. The goal is to present practice relevant data concisely and accurately.
Prostatepedia
Rivanna Health Publication’s Prostatepedia features informal conversations with doctors, patients, and activists about prostate cancer. Each month, we tackle a different topic facing prostate cancer patients today—from how imaging has impacted treatment, to dealing with erectile dysfunction after radiation or surgery, and to the evolving field of immunotherapy.
Associations & Foundations
ABS
Founded in 1978, the American Brachytherapy Society (ABS) is a nonprofit organization that seeks to provide insight and research into the use of brachytherapy in malignant and benign conditions. The organization consists of approximately 1,500 physicists, physicians, and other health care providers interested in brachytherapy.
The mission of the ABS is to benefit patients by providing information directly to the consumer, by promoting the highest possible standards of practice of brachytherapy, and to benefit health care professionals by encouraging improved and continuing education for radiation oncologists and other health care professionals involved in the treatment of cancer. Additionally, the ABS seeks to promote clinical and laboratory research into the frontiers of knowledge of the specialty and to study the socio-economic aspects of the practice of brachytherapy.
AdMeTech Foundation
AdMeTech Foundation is a 501(c)(3) non-profit organization providing global leadership in transforming early detection and treatment of life-threatening diseases. The Manogram® Project is dedicated to ending the prostate cancer crisis. The Manogram® Project reflects AdMeTech Foundation’s focus on ending the prostate cancer crisis. To achieve this goal, the Manogram® Project provides global leadership in expediting groundbreaking advances in prostate cancer care and their transfer to patients.
Large Urology Group Practice Association (LUGPA)
In 2008, when physician leaders of member urology practices began to recognize the need for a formal association to help meet the challenges of the future, the Large Urology Group Practice Association (LUGPA) was established with the purpose of enhancing communication among large groups, allowing for benchmarking of operations, promoting quality clinical outcomes, developing new opportunities, and improving advocacy in the legislative and regulatory arenas. LUGPA has modified its bylaws and now welcomes memberships for all physician colleagues, regardless of size. All urologists may benefit from the growing LUGPA network.
